A subsidiary of Singapore's Biosensors International can no longer sell devices in the U.S. because it failed to respond to a request for FDA inspection. Biosensors spokesman John Wong told Regulatory Focus that the company received the notification of FDA inspection on Dec. 21, 2015, or "over the holiday time. As we did not respond to FDA within the 5-day window as required by the FDA due to the holidays, we missed the required deadline. We have since responded affirmatively to FDA, which we welcome them to inspect. We are waiting for their response and are ready to provide further clarifications and support." This is the fifth instance of a company in Asia turning down an inspection request (whether intentionally or not). Read more from FiercePharmaAsia
@FierceMedDev: Second activist investor buys 5% stake in HeartWare, putting Valtech deal in doubt. Article | Follow @FierceMedDev
@VarunSaxena2: Interesting article in @TheEconomist. Which lifesci hub do you think is no. 1? More (reg. req.) | Follow @VarunSaxena2
@EmilyWFierce: Shkreli, Valeant CEO set for a grilling at Congressional price-hike hearing. FiercePharma story | Follow @EmilyWFierce
> Last year was a record one for medical device M&A deal closures--but new deal announcements have been scarce of late. Report
> Illumina ($ILMN) is sponsoring a contest for researchers that includes the MiniSeq Sequencing System and a 2016 MINI Cooper car as prizes. Applications will be collected until March 31 and judged on scientific merit, innovation and fit with the MiniSeq System. More
> Micro-cap Cardica ($CRDC) has nabbed FDA clearance for its MicroCutter Xchange 30 surgical stapling device for the transection and resection in open or minimally invasive urologic, thoracic, and pediatric surgical procedures. More
Biotech News
@FierceBiotech: Top 10 mega-rounds fuel record VC pace, with a distinctly ex-U.S. biotech accent. Report | Follow @FierceBiotech
@JohnCFierce: And in case you missed it: Eleven Bio faces cash crunch as lead drug flunks another PhIII. Article | Follow @JohnCFierce
@DamianFierce: Index Ventures' official Dick Costolo announcement is a link to his tweets of screenshots from his notes app. More | Follow @DamianFierce
> Samsung and Biogen win first EU approval for an Enbrel copycat. Report
> French drug trial disaster leaves patient dead amid a slew of unanswered questions. Story
> Acorda bags PhIII Parkinson's drug in $363M Biotie buyout. Article
Pharma News
@FiercePharma: New strain of avian flu confirmed in Indiana poultry flocks. FierceAnimalHealth item | Follow @FiercePharma
@EricPFierce: FDA says this Hong Kong plant pretty much had not quality control in place. FiercePharmaManfacturing story | Follow @EricPFierce
@CarlyHFierce: ICYMI: PTO shuts down Amgen's Humira IP challenge. Article | Follow @CarlyHFierce
> Shkreli, Valeant CEO set for a grilling at Congressional price-hike hearing. Report
> Supreme Court rebuffs another J&J appeal, leaving $140M failure-to-warn judgment intact. Article
Animal Health News
> New strain of avian flu confirmed in Indiana poultry flocks. Story
> Affymetrix teams with Bio-Genesys to offer genetic testing for livestock. More
> Animal drugs, diagnostics and distribution on display at J.P. Morgan confab. Item
> EMA launches review of 'last-resort' antibiotic after scientists ID resistance gene. Report
> Dechra's growth spurt continues with $6M acquisition of Mexican manufacturer. Article
Biotech IT News
> BioMed X emerges from Merck KGaA alliance armed with bioinformatics tools. News
> NIH kicks off $313M genome sequencing drive. Report
> Illumina moves into semiconductor-based sequencing with Project Firefly. More
> Biden puts data sharing at center of drive to cure cancer. Article
> Astellas hooks up with NuMedii to continue drug repurposing deal drive. Story
Drug Delivery News
> Dental anesthesia delivered via electric current could offer needle-free alternative. Item
> Will FDA panel's second recommendation of approval for implant to treat opioid addiction be enough? More
> Takeda teams up with enGene for gastrointestinal gene delivery R&D. Report
> Catalent to earn up to $618M under antibody-drug conjugate research alliance with Roche. Story
> Pfizer invests in 4D Molecular Therapeutics, a maker of gene delivery vectors. Article
Pharma Manufacturing News
> Mylan halts production at Poland plant after inspectors uncover problems. News
> Plant-based biologics production to be offered by new CMO. Item
> FDA slams another Chinese drugmaker with a warning letter. Story
> Emcure, which has issues with FDA, buys Canadian firms. Report
> Wockhardt's new sterile injectable plant issued a Form 483 by the FDA. Article
Pharma Asia News
> Unit of Singapore's Biosensors refuses U.S. FDA inspection. Item
> Redesigned scope by Japan's Olympus cleared by FDA. More
> Japanese drugmakers shift focus as government pushes for more generics. Report
> Sanofi may get waiver from large-scale dengue vaccine trials in India. Story
> Healthcare reform in China raises tensions between hospitals, pharma companies. Article